SBIR/STTR Research Award

Catalyst for promoting analyte derivatization inside a gas-chromatographic inlet

Award identifier f140f6821c87e075200010e2e8258d69fe9141ce6b5ae01813157ef42f169a9aAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$90,795

Program and phase

SBIR · Phase I

Award year

2006

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
CMS FIELD PRODUCTS
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
PHS2006-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): PROJECT SUMMARY: The proposed research will lead to the development of a hardware item, to be inserted into the inlet of a gas chromatograph (GC) that will catalyze "on-line" derivatizations of injected analytes inside the hot GC injection port. Such on-line derivatizations are now being done with the use of conventional glass GC inlet liners and other highly inert materials that are intended to discourage, rather than promote, inside-the-inlet chemical reactions. It is hypothesized that use of a suitable solid heterogeneous catalyst inside the GC inlet will significantly reduce the temperatures and/or reagent concentrations needed to drive many on-line derivatizations to completion. This product will be especially applicable to trace-level determinations of relatively low-molecular-weight compounds that lack the required volatility, stability, detectability, or intrinsic chromatographability to be effectively determined by GC instrumentation without the aid of derivatization. Such compounds may include amino acids, fatty acids, nucleosides, sugars, steroids, drugs, surfactants, vitamins, pollutants, toxins, metabolites, degradation products, impurities, and so on. The Phase I specific aims are: (1) to find several chemically diverse derivatization reactions that are clearly inefficient in an on-line mode under "baseline" conditions, i.e., in a conventionally configured GC inlet in the absence of a catalyst, and that can therefore serve effectively as model reactions during Phase I and Phase II evaluations of candidate catalysts; and (2) to evaluate an array of candidate catalysts with the selected model reactions in a GC inlet and to establish proof-of-principle by identifying at least one effective catalyst that clearly promotes at least one of the model derivatizations. The main goal of Phase II will be to find an optimally effective catalyst or suite of catalysts and to characterize the conditions under which the identified catalyst(s) can and cannot be expected to perform well. RELEVANCE: The proposed GC inlet accessory is expected to increase the usefulness of the GC analysis technique in a variety of clinical, industrial, academic, government, and other biomedical laboratory settings. Hence, it should lead to significant improvements in the speed, sensitivity, selectivity, accuracy, cost, and/or simplicity of diverse biomedically significant chemical analyses. For this reason, numerous public-health- related programs, functions, and objectives should benefit from this broadly enabling technology.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.